Luis Ángel Fernández

ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 18

Top Venues

Microbial biotechnology

Nucleic acids research

PLoS pathogens

Microbial cell factories

Centro Nacional de Biotecnología

Universidad Autónoma de Madrid (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Centro Nacional de Biotecnología Mar 15 2011

Spain

Principal Investigator- Investigador CSIC :: Microbial Biotechnology

Centro Nacional de Biotecnología Jul 01 2005 - Mar 14 2011

Spain

Principal Investigator- Científico Titular CSIC :: Microbial Biotechnology

Centro Nacional de Biotecnología Dec 01 2001 - Jun 30 2005

Spain

Investigador Ramón y Cajal :: Microbial Biotechnology

Education History

Universidad Autónoma de Madrid Oct 01 1990 - Jul 06 1995

Spain

PHD :: Departamento de Biología Molecular

Publications

Alejandro Asensio-Calavia, Álvaro Ceballos-Munuera, Almudena Méndez-Pérez, Beatriz Álvarez, Luis Ángel Fernández
A tuneable genetic switch for tight control of tac promoters in Escherichia coli boosts expression of synthetic injectisomes. Microbial biotechnology (2023)
Marta Robledo Garrido, Beatriz Álvarez, Ana Cuevas, Sheila González, David Ruano-Gallego, Luis Ángel Fernández, Fernando de la Cruz
Targeted bacterial conjugation mediated by synthetic cell-to-cell adhesions. Nucleic acids research 50 (22) (2023)
Marta Robledo Garrido, Beatriz Álvarez, Ana Cuevas, Sheila González, David Ruano-Gallego, Luis Ángel Fernández, Fernando de la Cruz
Targeted bacterial conjugation mediated by synthetic cell-to-cell adhesions. Nucleic acids research 50 (22) (2023)
Marta Robledo Garrido, Beatriz Álvarez, Ana Cuevas, Sheila González, David Ruano-Gallego, Luis Ángel Fernández, Fernando de la Cruz
Targeted bacterial conjugation mediated by synthetic cell-to-cell adhesions. Nucleic acids research 50 (22) (2023)
Lidia Cerdán, Beatriz Álvarez, Luis Ángel Fernández
Massive integration of large gene libraries in the chromosome of Escherichia coli. Microbial biotechnology (2023)
Marta Robledo Garrido, Beatriz Álvarez, Ana Cuevas, Sheila González, David Ruano-Gallego, Luis Ángel Fernández, Fernando de la Cruz
Targeted bacterial conjugation mediated by synthetic cell-to-cell adhesions. Nucleic acids research (2022)
Beatriz Álvarez, Víctor Muñoz-Abad, Alejandro Asensio-Calavia, Luis Ángel Fernández
Enhanced protein translocation to mammalian cells by expression of EtgA transglycosylase in a synthetic injector E. coli strain. Microbial cell factories 21 (1) (2022)
Elena Velázquez, Beatriz Álvarez, Luis Ángel Fernández, Victor de Lorenzo
Hypermutation of specific genomic loci of Pseudomonas putida for continuous evolution of target genes. Microbial biotechnology 15 (9) (2022)
Yamal Al-Ramahi, Akos Nyerges, Yago Margolles, Lidia Cerdán, Gyorgyi Ferenc, Csaba Pál, Luis Ángel Fernández, Victor de Lorenzo
ssDNA recombineering boosts in vivo evolution of nanobodies displayed on bacterial surfaces. Communications biology 4 (1) (2021)
David Ruano-Gallego, Julia Sanchez-Garrido, Zuzanna Kozik, Elena Núñez-Berrueco, Massiel Cepeda-Molero, Caroline Mullineaux-Sanders, Jasmine Naemi-Baghshomali Clark, Sabrina L Slater, Naama Wagner, Izabela Glegola-Madejska, Theodoros I Roumeliotis, Tal Pupko, Luis Ángel Fernández, Alfonso Rodríguez-Patón, Jyoti S Choudhary, Gad Frankel
Type III secretion system effectors form robust and flexible intracellular virulence networks. Science (New York, N.Y.) 371 (6534) (2021)
Elena M Seco, Luis Ángel Fernández
Efficient markerless integration of genes in the chromosome of probiotic E. coli Nissle 1917 by bacterial conjugation. Microbial biotechnology (2021)
Beatriz Álvarez, Mario Mencía, Victor de Lorenzo, Luis Ángel Fernández
In vivo diversification of target genomic sites using processive base deaminase fusions blocked by dCas9. Nature communications 11 (1) (2020)
David Ruano-Gallego, Daniel A Yara, Lorenza Di Ianni, Gad Frankel, Stephanie Schüller, Luis Ángel Fernández
A nanobody targeting the translocated intimin receptor inhibits the attachment of enterohemorrhagic E. coli to human colonic mucosa. PLoS pathogens 15 (8) (2019)
David Ruano-Gallego, Sofía Fraile, Carlos Gutierrez, Luis Ángel Fernández
Screening and purification of nanobodies from E. coli culture supernatants using the hemolysin secretion system. Microbial cell factories 18 (1) (2019)
Nicolas Kylilis, Pinpunya Riangrungroj, Hung-En Lai, Valencio Salema, Luis Ángel Fernández, Guy-Bart V Stan, Paul S Freemont, Karen Marie Polizzi
Whole-Cell Biosensor with Tunable Limit of Detection Enables Low-Cost Agglutination Assays for Medical Diagnostic Applications. ACS sensors 4 (2) (2019)
Massiel Cepeda-Molero, Cedric N Berger, Alistair D S Walsham, Samuel J Ellis, Simon Wemyss-Holden, Stephanie Schüller, Gad Frankel, Luis Ángel Fernández
Attaching and effacing (A/E) lesion formation by enteropathogenic E. coli on human intestinal mucosa is dependent on non-LEE effectors. PLoS pathogens 13 (10) (2017)
Valencio Salema, Luis Ángel Fernández
Escherichia coli surface display for the selection of nanobodies. Microbial biotechnology 10 (6) (2017)
Beatriz Álvarez, Luis Ángel Fernández
Sustainable therapies by engineered bacteria. Microbial biotechnology 10 (5) (2017)

Luis Ángel Fernández.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Luis Ángel Fernández